Live microorganisms with leaves that are used as food additions to provide health benefits are known as probiotics. Non-pathogenic yeast strains of Saccharomyces cerevisiae are known as probiotic yeasts. Probiotic yeast has been deemed preferable to probiotic bacteria due to the yeast’s innate resistance to antibacterial antibiotics.
The use of probiotic yeasts in animal feed benefits human health by enhancing fiber digestibility and improving animal performance, resulting in higher meat, milk, and egg outputs. Food-derived probiotic yeasts have been proven to help limit the toxicity of some fatal fungi that have developed resistance to widely used anti-fungal drugs, according to researchers from Mysore’s Central Food Technological Research Institute (CFTRI) and a counterpart from the United States.
The probiotic yeasts are particularly effective against Candida Auris, which has caused concern due to drug-resistant forms. The growing usage of probiotic yeast in pharmaceuticals has increased the probiotic yeast market’s potential for growth.
The probiotic yeast market’s growth potential has been broadened by the rising demand for high-quality animal by-products.
Probiotic yeast has been used in ruminant feed to boost health and milk output. In pigs, probiotic yeast generates an immunological response that reduces pathogen entry into the body and also reduces post-weaning diarrhea. In dairy cows, probiotic yeasts, particularly Saccharomyces cerevisiae, are commonly employed.
The inclusion of probiotic yeast in cow feed boosted the breeding performance of milking cows, according to a recent study. Dietary supplements are a well-established technique for increasing cattle performance across a wide range of criteria. The probiotic yeast market is expected to grow at the quickest rate during the forecast period, thanks to the growing usage of probiotics for animal nutrition, growth promotion, and gut health development.
The appearance of Saccharomyces boulardii as a promising probiotic organism is expected to boost demand for probiotic yeast.
Saccharomyces boulardii is gaining popularity as a potential probiotic. S. boulardii is a probiotic yeast used to treat a variety of gastrointestinal and digestive disorders. Enteral nutrition-related diarrhea, acute gastroenteritis, and traveler’s diarrhea have all been linked to this probiotic yeast. It’s a probiotic supplement that’s utilized all around the world to improve gastrointestinal health.
The efficiency and positive benefits of S. boulardii on acute and chronic gastrointestinal illnesses revealed in clinical research can be explained by its varied action mechanisms and characteristics. As a result, demand for Saccharomyces boulardii is increasing, leading to the expansion of the probiotic yeast market share.
Key Players in the Global Probiotic Yeast Market
Mystical Biotech, BIOGIT, Angel Yeast Co. Ltd., Jarrow Formulas, Pharma Nord, Lesaffre, and others are some of the major companies in the worldwide Probiotic yeast market.